Form 4 for CRVL CORVEL CORP
Accepted 2024-07-30 00:00:00 ET · period of report 2024-07-29 · accession 0000946724-24-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-30 | 2024-07-29 | CRVL | CLEMONS V GORDON | COB, Dir | F - Tax | $307.82 | -917 | 900.4K | -0.1% | -$282.3K |
| DM | 2024-07-30 | 2024-07-29 | CRVL | CLEMONS V GORDON | COB, Dir | M - OptEx | $125.27 | +1,379 | 900.4K | +0.2% | +$172.7K |
| DM | 2024-07-30 | 2024-07-29 | CRVL | CLEMONS V GORDON | COB, Dir | M - OptEx | $307.82 | -1,379 | 271 | -84% | -$424.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-29 | F | D | 51 | $307.82 | 900,492 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-29 | F | D | 132 | $307.82 | 900,543 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-29 | M | A | 250 | $163.61 | 900,675 | D | — | — | |
| 4 | Common | Common Stock | 2024-07-29 | F | D | 162 | $307.82 | 900,425 | D | — | — | |
| 5 | Common | Common Stock | 2024-07-29 | F | D | 359 | $307.82 | 900,587 | D | — | — | |
| 6 | Common | Common Stock | 2024-07-29 | M | A | 729 | $151.94 | 900,946 | D | — | — | |
| 7 | Common | Common Stock | 2024-07-29 | F | D | 145 | $307.82 | 900,217 | D | — | — | |
| 8 | Common | Common Stock | 2024-07-29 | F | D | 68 | $307.82 | 900,362 | D | — | — | |
| 9 | Common | Common Stock | 2024-07-29 | M | A | 400 | $52.69 | 900,430 | D | — | — | |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-07-29 | M | D | 400 | $307.82 | 0 | D | $52.69 · — to 2025-04-30 | 400 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-07-29 | M | D | 250 | $307.82 | 750 | D | $163.61 · — to 2027-08-04 | 250 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-07-29 | M | D | 729 | $307.82 | 271 | D | $151.94 · — to 2026-08-12 | 729 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |